Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | — | SEC | |
| Other | $148.9K | SEC | |
| ExerciseD | — | SEC | |
| AwardD | $34.8K | SEC | |
| AwardD | $37.7K | SEC | |
| Buy | $31.3K | SEC | |
| Buy | $66K | SEC | |
| Exercise | $15.4K | SEC | |
| AwardD | $27.5K | SEC | |
| Buy | $79.7K | SEC | |
| AwardD | $27.5K | SEC | |
| Exercise | $79.7K | SEC | |
| AwardD | $37.4K | SEC | |
| AwardD | $36.8K | SEC | |
| AwardD | $33.2K | SEC | |
| AwardD | $32.1K | SEC | |
| Buy | $38.4K | SEC | |
| Buy | $531.6 | SEC | |
| Buy | $45.8K | SEC | |
| AwardD | $2.9B | SEC | |
| AwardD | $1.5B | SEC | |
| AwardD | $1.1B | SEC | |
| Buy | $647.7K | SEC | |
| Buy | $323.8K | SEC | |
| Award | $250K | SEC |